Oncology claims reach a 98% first-pass rate through precise review of infusion coding, diagnosis linkage, and drug administration documentation.
High-touch follow-up on drug denials, prior authorizations, and underpaid infusion claims reduces outstanding A/R by 40% for oncology providers.
Certified coders maintain 98% accuracy across chemotherapy, supportive therapy, prolonged infusions, and modifier-sensitive outpatient services.
Stronger charge capture and denial recovery increase net collections by 15% for oncology groups managing high-cost medications and recurring treatment cycles.

Our oncology billing team understands how quickly revenue erodes when infusion documentation, drug units, and payer authorizations are not aligned from the start.
Specialty billing teams review infusion, injection, and oncology drug coding patterns before claims move to payers.
Automated checks flag unit mismatches, authorization gaps, and diagnosis-linking issues before submission.
We reconcile nursing documentation, physician orders, and drug administration details against billed services.
Dedicated oncology workflows accelerate claim submission and payment posting across recurring treatment cycles.
All oncology billing activity is managed in secure HIPAA-compliant systems with careful access controls and audit trails.
Denial specialists pursue drug, infusion, and medical necessity appeals before high-value revenue is lost.
We ensure compliance with:

MedVoice Healthcare Services strictly maintain compliance with HIPAA, and all government data regulations within the countries we do business. Our data and information management system and policies ensure compliance through securing confidential information, utilizing compliant and secure data accessing practices, and promoting leading security measures to all MedVoice employees. MedVoice staff are trained on an ongoing and routine basis to continuously ensure data and information security.
Copyright © 2026MedVoice. All Rights Reserved. Sitemap.